Artal Group S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 3,000,000 shares at $2.25 ($6.8M) on 2012-10-23, disclosed to the SEC on 2012-10-25.
Open-market purchase of $6.8M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| CAVA | SELL | 2024-06-07 | $261.8M | — | Filing → |
| LXRX | BUY | 2023-06-05 | $72.2M | — | Filing → |
| GLYC | BUY | 2023-02-23 | $711K | — | Filing → |